Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment-Reference-Cited by-同舟云学术

Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment

Published:2011-12 Issue:12 Volume:40 Page:e543-e560
ISSN:0755-4982
Container-title:La Presse Médicale
language:en
Short-container-title:La Presse Médicale

Author:

Umberto Meduri Gianfranco,Bell William,Sinclair Scott,Annane Djillali

Publisher

Elsevier BV

Subject

General Medicine

Reference130 articles.

1. Diffuse alveolar damage: the role of oxygen, shock and related factors. A review;Katzenstein;Am J Pathol,1976

2. Corticosteroids in acute respiratory failure;Jantz;Am J Respir Crit Care Med,1999

3. An expanded definition of the adult respiratory distress syndrome;Murray;Am Rev Respir Dis,1988

4. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy;Meduri;Chest,2009

5. Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome;Meduri;Crit Care,2002

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Treatment of Tubal Inflammatory Infertility using Yinjia Tablets through EGFR/MEK/ERK Signaling Pathway based on Network Pharmacology;Current Pharmaceutical Biotechnology;2024-03

2. Glucocorticoid Treatment in Acute Respiratory Distress Syndrome: An Overview on Mechanistic Insights and Clinical Benefit;International Journal of Molecular Sciences;2023-07-28

3. Methylprednisolone pulse therapy for critically ill patients with COVID-19: a cohort study;Acute and Critical Care;2023-02-28

4. The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis;Frontiers in Neurology;2021-11-04

5. Preventing the development of severe COVID-19 by modifying immunothrombosis;Life Sciences;2021-01